Abstract
In this review, we evaluate the role of viral and host genetics in the natural history and treatment outcomes of
chronic HCV infection, and consider how this knowledge might
help individualize clinical management in the era of DAA therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 413 - 427 |
| Number of pages | 15 |
| Journal | Best Practice & Research: Clinical Gastroenterology |
| Volume | 26 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2012 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver